CAPR
CAPR
NASDAQ · Biotechnology

Capricor Therapeutics Inc

$9.06
-0.36 (-3.82%)
As of Sep 20, 10:12 PM ET ·
Analyst Consensus
Hold
16
Analysts
High
Coverage
Buy 7 44%
Hold 9 56%
Sell 0 0%
Price Target
Analyst Price Target +589.2% upside
Low Target $34.96
Average Target $62.44
High Target $82.04
Current Price $9.06
Current
$9.06
Target
$62.44
$34.96 $62.44 avg $82.04
Scenario Analysis
Bear Case
$34.96
285.9%
Low target
Base Case
$62.44
+589.2%
Avg target
Bull Case
$82.04
+805.5%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$40.37
-77.6% from high
52-Week Low
$2.96
+206.1% from low
Target vs 52W High
$62.44
+54.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%